ACUTA CAPITAL PARTNERS, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 120 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$11,173,000
-47.9%
770,000
-27.2%
5.42%
+2.1%
Q4 2019$21,425,000
+372.0%
1,057,500
+24.4%
5.31%
+62.0%
Q3 2019$4,539,000
-26.2%
850,000
-9.1%
3.28%
+49.7%
Q2 2019$6,152,000
+109.5%
935,000
+133.8%
2.19%
+214.4%
Q1 2017$2,936,000
+39.8%
400,000
-60.0%
0.70%
-10.9%
Q4 2016$2,100,000
+95.9%
1,000,000
+165.0%
0.78%
+25.8%
Q3 2015$1,072,000
-32.4%
377,427
-28.1%
0.62%
-36.6%
Q2 2015$1,585,000
-15.5%
524,751
+22.0%
0.98%
-37.9%
Q1 2015$1,875,000430,0001.58%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders